Who
Maximo F. Nougues
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Puma Biotechnology.
In numbers
- Trades disclosed
- 56
- Buys
- 0
- Sells
- 36
- Bought
- $0
- Sold
- $650K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Nov 2018
- Last trade
- 6 Jul 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jul 2026filed 8 Jul 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $78K9,386 at $8.26 | filing |
| 6 Jul 2026filed 8 Jul 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $78K9,386 at $8.26 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —46,739 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,541 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,541 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —46,739 at $0.00 | filing |
| 7 Jan 2026filed 8 Jan 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $38K6,405 at $5.88 | filing |
| 7 Jan 2026filed 8 Jan 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $38K6,405 at $5.88 | filing |
| 6 Jan 2026filed 8 Jan 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $27K4,540 at $5.84 | filing |
| 6 Jan 2026filed 8 Jan 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $27K4,540 at $5.84 | filing |
| 9 Jul 2025filed 10 Jul 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $14K3,935 at $3.54 | filing |
| 8 Jul 2025filed 10 Jul 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $20K5,587 at $3.53 | filing |
| 7 Feb 2025filed 11 Feb 2025 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,067 at $0.00 | filing |
| 7 Feb 2025filed 11 Feb 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —61,456 at $0.00 | filing |
| 2 Jan 2025filed 3 Jan 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $32K10,227 at $3.15 | filing |
| 17 Jul 2024filed 18 Jul 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $15K4,156 at $3.70 | filing |
| 2 Jul 2024filed 2 Jul 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $17K5,295 at $3.27 | filing |
| 12 Feb 2024filed 14 Feb 2024 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —59,946 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —43,307 at $0.00 | filing |
| 3 Jan 2024filed 5 Jan 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $70K15,682 at $4.49 | filing |
News
No headline names them, or the companies they trade most, lately.